Seyed-Mohammad-Reza Hosseini

Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder

S. Akhondzadeh, A. Modabbernia, M. Ashrafi, 2012, CNS Drugs.

From a simple chronic headache to neurobrucellosis: a case report

A. Tafakhori, V. Aghamollaii, Masih Tajdini, 2014, Medical journal of the Islamic Republic of Iran.

Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive–compulsive disorder

S. Akhondzadeh, M. Zarei, Jalil Fallah, 2014, International clinical psychopharmacology.

Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia

S. Akhondzadeh, A. Ghaleiha, B. Salehi, 2012, CNS Drugs.

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study

S. Akhondzadeh, B. Salehi, A. Modabbernia, 2014, Psychiatry Research.

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

S. Akhondzadeh, B. Salehi, Seyedaghanoor Sadeghi, 2013, Clinical neuropharmacology.

Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: A randomized, double-blind, placebo-controlled, clinical trial

S. Akhondzadeh, A. Ghaleiha, B. Salehi, 2014, European Neuropsychopharmacology.

A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia

S. Akhondzadeh, B. Salehi, M. Farokhnia, 2014, Psychopharmacology.

A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia

M. Noroozian, S. Akhondzadeh, B. Salehi, 2013, Psychopharmacology.